Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
AbbVie's Skyrizi continues booming growth trajectory
As Humira continues its sales free fall, newer Skyrizi proved a worthy successor over the first quarter with nearly matching sales.
Zoey Becker
Apr 26, 2024 12:06pm
Sponsored
3 Principles to Optimize Patient Support Programs
Apr 22, 2024 8:00am
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Pfizer will charge $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am
Marketing News
Medtronic backs push to activate heart valve disease patients
Apr 26, 2024 7:35am
Neurocrine asks ‘What the C@H?!’ in new hyperplasia campaign
Apr 25, 2024 12:04pm
Biogen plots 30% Leqembi field force bump, omnichannel campaigns
Apr 25, 2024 6:58am
Roche's juggernaut Vabysmo routs analyst consensus
Apr 24, 2024 11:29am
See More Marketing News